The Bernstein downgrade is the most aggressive call on NVDA, but its below-average accuracy tempers its standalone weight. The real signal is the convergence of four downgrades in 30 days with material insider selling, creating a bearish setup that the consensus has not yet priced in, especially with earnings five days away.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $166.19entry
- T+1 · 4d ago −2.01%α −1.65% · $162.85
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Bernstein downgraded NVDA from Outperform to Market Perform on November 12, slashing its price target 50% to $200 from $400, the most aggressive cut among four downgrades today. The stock closed at $173.73, already below the new target, implying just 15% upside. Bernstein's 44% accuracy on 548 calls is below the peer average, but the magnitude of the PT cut signals deep concern. Consensus remains heavily bullish at 97% Buy/Strong Buy (66 of 69 analysts), though four downgrades in the last 30 days mark a sharp reversal in momentum. The mean price target of $319.99 still implies 84% upside, but the low target of $180 is now just 4% above the current price. Earnings are due November 17, adding timing pressure. Insider selling has been material, director Mark Stevens sold $298M on September 18, and EVP Timothy Teter sold $6.8M under a 10b5-1 plan on September 21. Institutional buying remains strong, with five funds adding positions worth $5.3B combined. The divergence between bullish consensus and accelerating downgrades creates a high-conviction contrarian setup.
Impact Score
Consensus & Targets
Consensus is heavily bullish: 25 Strong Buy, 41 Buy, 2 Hold, 1 Sell, 0 Strong Sell, 97% Buy/Strong Buy from 69 analysts. The direction is strongly bullish, but the four downgrades in the last 30 days (including today's) are a notable crack in that consensus.
Mean price target is $319.99, median $315, high $515, low $180. Current price $173.73 implies 84% upside to the mean. Bernstein's $200 target is 37% below the mean and just above the low of $180, placing it among the most bearish on the Street.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-12 | Bernstein | downgrade | Market Perform | $200.00 |
| 2026-11-12 | Cantor Fitzgerald | maintain | Overweight | $250.00 |
| 2026-11-12 | Evercore ISI Group | downgrade | In-Line | $186.00 |
| 2026-11-12 | Oppenheimer | downgrade | Perform | No target |
| 2026-11-11 | Morgan Stanley | reiterate | Overweight | $300.00 |
| 2026-11-11 | Baird | downgrade | Neutral | $200.00 |
| 2026-11-10 | Citigroup | maintain | Buy | $285.00 |
| 2026-11-10 | Wells Fargo | maintain | Overweight | $300.00 |
| 2026-11-09 | RBC Capital | reiterate | Outperform | $330.00 |
| 2026-11-09 | Goldman Sachs | reiterate | Buy | $300.00 |
30-day analyst activity shows 0 upgrades and 4 downgrades, a clear negative shift. EPS revisions are mixed: the +1y estimate saw 7 upward revisions and 0 downward in 30 days, but the current quarter (0q) had 1 downward revision. The +1y EPS average edged down from $15.9146 to $15.90883 in 7 days, suggesting slight downward pressure.
Firm Track Record: Bernstein
Bernstein accuracy: 44% on 548 calls | avg return: 3.2%
Industry benchmark: mean 45% ± 8%. Top tier: ≥53% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| New Street Research | 100% | 2/2 | 19.5% | top tier |
| Raymond James | 86% | 6/7 | 26.4% | top tier |
| Piper Sandler | 71% | 5/7 | 20.3% | top tier |
| Rosenblatt | 65% | 15/23 | 12.3% | top tier |
| Tigress Financial | 60% | 3/5 | -1.8% | top tier |
| Loop Capital | 60% | 3/5 | 4.6% | top tier |
| RBC Capital | 60% | 3/5 | 5.7% | top tier |
| Barclays | 60% | 6/10 | 13.7% | top tier |
| Benchmark | 60% | 9/15 | 9% | top tier |
| Needham | 57% | 8/14 | 11.1% | top tier |
Bernstein has a 44% accuracy rate on 548 calls, below the peer average. Their average return of 3.2% also trails top-tier firms like Raymond James (86% accuracy, 26.4% return) and Piper Sandler (71% accuracy, 20.3% return). This is a low-accuracy firm making a high-conviction contrarian call.
Earnings Estimates
Next earnings: Nov 17, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $15.91 | $12.85 to $18.75 | $691.4B | ↑3 ↓0 |
| 0q | $2.47 | $2.34 to $2.70 | $109.0B | ↑0 ↓0 |
| +1q | $2.75 | $2.56 to $3.12 | $124.7B | ↑0 ↓0 |
| 0y | $9.32 | $9.01 to $10.10 | $411.9B | ↑2 ↓0 |
Cross-Platform Signals
Insider selling is material: director Mark Stevens sold $298M on September 18 (non-10b5-1), and EVP Timothy Teter sold $6.8M under a 10b5-1 plan on September 21. These sales total ~0.0075% of market cap, below the 0.1% threshold for a strong bearish signal, but the $298M director sale is notable. Congressional activity is mixed: two buys (Rep. Salazar, Oct 23) and three sells (Reps. Cisneros, Khanna, Sessions) in October, all small amounts. Institutional buying is strong, five funds added $5.3B combined, with increases of 26-35%. No short-sale volume data available. The insider selling and downgrades converge bearishly, but institutional buying diverges as a bullish counterweight.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
62 reports on NVDA
5 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +18.74% at T+60 after the Feb 25, 2026 report. 19 of 20 went positive at some point.
Filters
- Nov 16, 2026today 13F-HR Neutral 3/10 Entry $156.72 Now $162.85 +3.91% settles Feb 16
- Nov 16, 2026today Press Release Neutral 3/10 Entry $158.77 Now $162.85 +2.57% settles Feb 12
- Nov 13, 20263d ago ANALYST-DOWNGRADE Bearish 6/10 Entry $162.85 Now $162.85 −0.00% settles Feb 11
- Nov 12, 20264d ago ANALYST-DOWNGRADE Bearish 7/10 Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 12, 20264d ago 8-K Bearish 7/10 Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 12, 20264d ago Press Release Bearish 7/10 Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 12, 20264d ago ANALYST-DOWNGRADE Bearish 6/10 Viewing Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 12, 20264d ago ANALYST-DOWNGRADE Bearish 7/10 Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 11, 20265d ago ANALYST-DOWNGRADE Bearish 4/10 Entry $173.73 Now $162.85 +6.26% settles Feb 9
- Nov 9, 20266d ago Institutional Cluster Neutral 3/10 Entry $168.89 Now $162.85 −3.58% settles Feb 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers